Skip to content
Screener

Arcutis Biotherapeutics, Inc. ARQT Future payable milestone payment

Future payable milestone payment at other companies

Climb Bio, Inc. logo
Climb Bio, Inc.CLYM
$8M—
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$4M—
Innoviva, Inc. logo
Innoviva, Inc.INVA
$17.5M—
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$500K—
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$77M0.0%
Royalty Pharma logo
Royalty PharmaRPRX
$12.5M0.0%

Other financials

Income statement

See full
Revenue$129.9M+59.3%
Gross profit$118.9M+60.7%
Operating income$16.4M+212%
Net income$15.0M+194%
EPS (diluted)$0.11+185%

Balance sheet

See full
Cash & equivalents$34.4M-52.9%
Total debt$114.1M+3.6%
Total equity$220.6M+58.7%
Total assets$488.5M+38.6%

Cash flow

See full
Operating cash flow$12.6M—
CapEx$158.0K+103%
Free cash flow$12.5M—

Valuation

See full
Market cap$3.39B+85.1%
Enterprise value$3.47B+85.7%
P/S7.3×+0.4×

Profitability

See full
Gross margin91.1%+2.0pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.5×-0.3×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept arqt:AssetAcquisitionPaymentsMilestonesOrRoyaltiesFuturePayableAmount.

The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001787306-26-000051
Line itemJune 30, 2026December 31, 2025
Accrued sales deductions$107,754$78,308
Accrued compensation15,50720,533
Accrued Ducentis milestone9,198—
Accrued expenses and other current liabilities14,32717,469
Total accrued liabilities$146,786$116,310

Item 1. Financial Statements (Unaudited)

FAQ

What is Arcutis Biotherapeutics, Inc.'s future payable milestone payment?
Arcutis Biotherapeutics, Inc. (ARQT) reported future payable milestone payment of $9.2M in Q2 2026.
What does future payable milestone payment mean?
Future payable milestone payment as reported by Arcutis Biotherapeutics, Inc. Common Stock.

Ask your AI about Arcutis Biotherapeutics, Inc.'s future payable milestone payment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude